News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Geoffrey Wade
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2023 |
4
| Smith Geoffrey Wade (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Exercised 758 options to buy
@ $0
Exercised 43,761 options to buy
@ $0
Exercised 228,073 options to buy
@ $0
Exercised 55,783 options to buy
@ $0 |
|
| 05/08/2023 |
4/A
| Smith Geoffrey Wade (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 1,516 options to buy
@ $0
Granted 87,522 options to buy
@ $0
Granted 456,146 options to buy
@ $0
Granted 111,566 options to buy
@ $0 |
|
| 01/30/2023 |
4
| Smith Geoffrey Wade (Director) has filed a Form 4 on Orchestra BioMed Holdings, Inc.|
Txns:
| Granted 3,488 shares
@ $0
Granted 201,319 shares
@ $0
Granted 1,049,224 shares
@ $0
Granted 256,623 shares
@ $0
Granted 43,940 warrants
@ $21.5054, valued at
$944.9k
Granted 136,097 warrants
@ $21.5054, valued at
$2.9M
Granted 519 warrants
@ $21.5054, valued at
$11.2k
Granted 18,600 options to buy
@ $4.3011, valued at
$80k
Granted 6,975 options to buy
@ $4.3011, valued at
$30k
Granted 23,250 options to buy
@ $10, valued at
$232.5k
|
|
| 01/30/2023 |
3
| Smith Geoffrey Wade (Director) has filed a Form 3 on Orchestra BioMed Holdings, Inc. |
|
|